Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloproliferative Disorders | 3 | 2019 | 604 | 0.990 |
Why?
|
| Primary Myelofibrosis | 2 | 2022 | 197 | 0.820 |
Why?
|
| Hematologic Neoplasms | 3 | 2021 | 1693 | 0.750 |
Why?
|
| Schistosomiasis mansoni | 1 | 2018 | 77 | 0.680 |
Why?
|
| Schistosoma mansoni | 1 | 2018 | 139 | 0.650 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2014 | 1136 | 0.620 |
Why?
|
| Lymphoma | 2 | 2021 | 1883 | 0.560 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2014 | 618 | 0.540 |
Why?
|
| Paired Box Transcription Factors | 1 | 2015 | 215 | 0.520 |
Why?
|
| Intermediate Filament Proteins | 1 | 2014 | 273 | 0.480 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2015 | 240 | 0.480 |
Why?
|
| Cell Hypoxia | 2 | 2013 | 682 | 0.420 |
Why?
|
| Epidermis | 1 | 2014 | 536 | 0.410 |
Why?
|
| Hodgkin Disease | 1 | 2018 | 1437 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 8560 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2013 | 986 | 0.380 |
Why?
|
| Bone Marrow | 2 | 2022 | 2922 | 0.370 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2015 | 1593 | 0.360 |
Why?
|
| Cell Death | 1 | 2013 | 1720 | 0.320 |
Why?
|
| Mutation | 3 | 2019 | 29253 | 0.250 |
Why?
|
| Sarcoma | 1 | 2015 | 1879 | 0.250 |
Why?
|
| Gout | 2 | 2022 | 539 | 0.240 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9494 | 0.230 |
Why?
|
| Colonic Neoplasms | 2 | 2013 | 2528 | 0.210 |
Why?
|
| Oxygen | 1 | 2013 | 4165 | 0.210 |
Why?
|
| Dioxygenases | 1 | 2022 | 313 | 0.200 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2021 | 1251 | 0.200 |
Why?
|
| Splenic Neoplasms | 1 | 2021 | 98 | 0.200 |
Why?
|
| Keratinocytes | 2 | 2014 | 791 | 0.180 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2021 | 180 | 0.180 |
Why?
|
| Thrombocytosis | 1 | 2018 | 86 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 2879 | 0.160 |
Why?
|
| Prednisolone | 1 | 2018 | 336 | 0.160 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11238 | 0.160 |
Why?
|
| Bone Marrow Examination | 1 | 2017 | 165 | 0.160 |
Why?
|
| Philadelphia Chromosome | 1 | 2017 | 107 | 0.160 |
Why?
|
| Calreticulin | 1 | 2017 | 110 | 0.150 |
Why?
|
| Vincristine | 1 | 2018 | 1038 | 0.150 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2017 | 158 | 0.150 |
Why?
|
| Fibrosis | 2 | 2022 | 1916 | 0.150 |
Why?
|
| Microarray Analysis | 1 | 2019 | 775 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2017 | 200 | 0.140 |
Why?
|
| Dacarbazine | 1 | 2018 | 588 | 0.140 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2014 | 39 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 516 | 0.130 |
Why?
|
| Selection, Genetic | 1 | 2019 | 885 | 0.130 |
Why?
|
| Laryngeal Diseases | 1 | 2017 | 253 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2021 | 2734 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2018 | 2200 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2013 | 199 | 0.110 |
Why?
|
| Vocal Cords | 1 | 2017 | 504 | 0.110 |
Why?
|
| Permeability | 1 | 2014 | 786 | 0.110 |
Why?
|
| Osteoporosis | 1 | 2021 | 1563 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2021 | 3387 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 2937 | 0.110 |
Why?
|
| Apoptosis | 1 | 2008 | 9960 | 0.110 |
Why?
|
| Cathepsins | 1 | 2013 | 287 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2019 | 5933 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1515 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3424 | 0.090 |
Why?
|
| Phosphotransferases | 1 | 2010 | 305 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2019 | 2515 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 1412 | 0.090 |
Why?
|
| Animals | 12 | 2022 | 169173 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2536 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 2644 | 0.090 |
Why?
|
| Autophagy | 1 | 2017 | 1311 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2013 | 989 | 0.090 |
Why?
|
| Mice | 8 | 2022 | 80270 | 0.090 |
Why?
|
| Humans | 21 | 2022 | 715594 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2014 | 19892 | 0.080 |
Why?
|
| Dimerization | 1 | 2008 | 905 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 1835 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2017 | 3064 | 0.070 |
Why?
|
| Protein Methyltransferases | 1 | 2005 | 55 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2094 | 0.070 |
Why?
|
| Colon | 1 | 2013 | 1758 | 0.070 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 2124 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 3290 | 0.060 |
Why?
|
| Acetamides | 1 | 2005 | 250 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1422 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5995 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 16726 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2008 | 3800 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 28991 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 2460 | 0.050 |
Why?
|
| Aged | 5 | 2021 | 162392 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2021 | 417 | 0.050 |
Why?
|
| Alendronate | 1 | 2021 | 174 | 0.050 |
Why?
|
| Middle Aged | 6 | 2021 | 214639 | 0.050 |
Why?
|
| Male | 7 | 2021 | 350143 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10600 | 0.050 |
Why?
|
| Inflammation | 1 | 2019 | 10090 | 0.050 |
Why?
|
| Cytogenetic Analysis | 1 | 2018 | 306 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2022 | 443 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 269 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 626 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2021 | 733 | 0.040 |
Why?
|
| Interleukins | 1 | 2021 | 799 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2022 | 964 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 870 | 0.040 |
Why?
|
| Uric Acid | 1 | 2022 | 739 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2019 | 903 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 12285 | 0.030 |
Why?
|
| Models, Biological | 2 | 2010 | 9810 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 15040 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 1805 | 0.030 |
Why?
|
| DNA | 1 | 2008 | 7084 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2022 | 11644 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 3894 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1954 | 0.030 |
Why?
|
| Monocytes | 1 | 2022 | 2627 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1835 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2021 | 1989 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2017 | 719 | 0.030 |
Why?
|
| Child | 1 | 2018 | 74413 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2010 | 23705 | 0.020 |
Why?
|
| Adult | 3 | 2021 | 212237 | 0.020 |
Why?
|
| Female | 4 | 2021 | 377052 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2010 | 298 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 2983 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2017 | 1379 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 6028 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9730 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 13209 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12495 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2010 | 1371 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13219 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 13619 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2021 | 11942 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 3569 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22636 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 24794 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 4043 | 0.010 |
Why?
|
| ras Proteins | 1 | 2005 | 1101 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 4692 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 3843 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 13203 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58293 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 16559 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 16302 | 0.000 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_